Sign in

    Justin Michetti • Sidoti & Company

    Justin Michetti is an Equity Research Analyst at Sidoti & Company, specializing in small and micro-cap companies across sectors such as industrials, technology, and consumer goods. As part of Sidoti’s research team since November 2024, he contributes to in-depth equity analysis on a range of covered companies, although specific names and performance metrics are not publicly disclosed. Prior to joining Sidoti, Michetti’s earlier professional record and analyst track record are not available in current public registries, and third-party performance ratings or success metrics have yet to be reported. His regulatory or licensing credentials, including FINRA registration and securities licenses, are not published in accessible industry databases and remain unverified as of this profile.

    Justin Michetti's questions to Ultralife Corp (ULBI) leadership

    Justin Michetti's questions to Ultralife Corp (ULBI) leadership • Q1 2025

    Question

    Justin Michetti of Sidoti & Company asked for an update on demand trends in the government, defense, and medical end markets, and inquired about the outlook for free cash flow generation throughout 2025.

    Answer

    Executive Michael Manna noted steady demand in the medical market, driven by predictable battery replacement cycles, including for devices fielded during the COVID era. In government and defense, he expects continued strength due to global conflicts and increased NATO spending. Executive Philip A. Fain projected consistent free cash flow for the remainder of 2025, citing lessons learned from the prior year and a focus on level-loading operations, which will support accelerated debt repayment.

    Ask Fintool Equity Research AI